Table 1.
Sample characteristics (%).
| Total | Breast | Prostate | Colorectal | Gyn. | |
|---|---|---|---|---|---|
| N = 1071 | N = 247 | N = 314 | N = 274 | N = 236 | |
| Current age | |||||
| 65–74 | 43.4 | 36.4 | 40.5 | 43.4 | 41.5 |
| 75–84 | 26.0 | 27.5 | 25.5 | 22.6 | 29.2 |
| 85+ | 30.6 | 36.0 | 23.9 | 33.9 | 29.2 |
| Race/ethnicity | |||||
| Non-Hispanic, White | 33.6 | 31.5 | 25.7 | 33.1 | 42.3 |
| Hispanic, White | 19.6 | 19.8 | 24.4 | 17.3 | 16.9 |
| African American | 24.3 | 24.6 | 26.0 | 26.5 | 21.1 |
| Asian American | 22.4 | 24.1 | 23.9 | 23.2 | 19.7 |
| Gender | |||||
| Male | 38.4 | — | 100 | 50.6 | — |
| Female | 61.6 | 100 | — | 49.4 | 100 |
| Education | |||||
| <High school | 9.9 | 7.3 | 12.4 | 10.9 | 8.8 |
| High school/GED | 17.0 | 18.9 | 14.9 | 16.3 | 18.0 |
| Some college/technical school | 36.2 | 33.5 | 30.2 | 41.5 | 40.1 |
| College graduate (or more) | 36.9 | 39.6 | 42.5 | 31.3 | 33.1 |
| Health insurance | |||||
| Yes | 97.1 | 97.2 | 97.8 | 97.0 | 96.4 |
| No | 2.9 | 2.8 | 2.2 | 3.0 | 3.6 |
| Stage (SEER) | |||||
| Localized | 45.6 | 74.4 | — | 48.3 | 62.9 |
| Regional | 21.3 | 23.9 | — | 49.1 | 14.2 |
| Distant | 6.8 | 1.5 | 1.3 | 1.5 | 20.6∗ |
| Localized/regional (prostate only) | — | — | 95.7 | — | — |
| Unstaged | 1.8 | 0.3 | 3.1 | 1.0 | 2.2 |
| Comorbid medical conditions | |||||
| Mean (std) | 5.4 ± 3.7 | 5.7 ± 4.0 | 4.8 ± 3.3 | 5.3 ± 3.6 | 5.6 ± 3.5 |
| Current symptoms | |||||
| Mean (std) | 6.3 ± 4.7 | 6.7 ± 4.4 | 5.2 ± 4.4 | 5.8 ± 4.7 | 7.2 ± 4.9 |
∗The high rate of distant disease in the gynecologic group reflects higher rates of distant disease in African American women with endometrial cancer, which is comparable to rates in the US population.